Dapagliflozin fda pdf version

As the drug was recently approved, there is the need for. Revised version submitted to clinical pharmacokinetics drugdrug interactions with sglt2 inhibitors, new oral glucoselowering agents for the management of type 2 diabetes. Fda rejects dapagliflozin for type 2 diabetes medpage today. Dapagliflozin was the first of its class inhibitors of sodiumglucose cotransporter to be approved in europe, usa, and brazil. Dapagliflozin is a cglycosyl comprising betadglucose in which the anomeric hydroxy group is replaced by a 4chloro34ethoxybenzylphenyl group. Persons with disabilities having problems accessing the pdf files below may. Headtohead comparison of empagliflozin and dapagliflozin. Pdf pharmacokinetics, pharmacodynamics and clinical efficacy of. Act fdca for farxiga dapagliflozin tablets 5 mg and 10 mg. Farxiga dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus see.

Dapagliflozin in patients with type 2 diabetes mellitus ncbi. Farxiga drug profile send this page by email email this page to a colleague. Fda strengthens kidney warnings for diabetes medicines canagliflozin invokana, invokamet and dapagliflozin farxiga, xigduo xr. Farxiga dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic. Sodiumglucose cotransporter 2 sglt2 inhibitors are a novel class of antihyperglycaemic agents with an insulinindependent mode of action. Dapagliflozin is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

Dapagliflozin a breakthrough in the search for drugs to. Update on longterm efficacy and safety of dapagliflozin. Adverse effects and safety of sglt2 inhibitors emconsulte. Persons with disabilities having problems accessing the pdf files below may call 301 7963634 for assistance. You must check to make sure that it is safe for you to take dapagliflozin with all of your drugs and health problems. Data sources include ibm watson micromedex updated 28 feb 2020, cerner multum updated 2 mar 2020, wolters kluwer updated. You may report side effects to fda at 1800 fda 1088. There are five tentative approvals for the generic drug dapagliflozin. Dapagliflozin is used along with diet and exercise, and sometimes with other medications, to lower blood sugar levels in patients with type 2 diabetes condition in which blood sugar is too. Each tablet contains 5 mg dapagliflozin equivalent to 6. Xigduo xr 5 mg mg, the equivalent of 10 mg dapagliflozin as. What are some things i need to know or do while i take dapagliflozin. Efficacy and safety of dapagliflozin, added to therapy of.

Administration with a highfat meal decreased peak plasma concentration by up to 50% and prolonged time to peak plasma concentration by approximately 1 hour, but did. The fda submission file reported nine breast cancers in 4 287 patients receiving. Fda requires additional data to assess imbalances in bladder cancer and drug. Dapagliflozin is a sodiumglucose cotransporter2 inhibitor that lowers plasma glucose by decreasing its renal reabsorption. Farxiga dapagliflozin is indicated as an adjunct to diet and exercise to.

Fda warns that sglt2 inhibitors for diabetes may result in. Dapagliflozin is an oral diabetes medicine that helps control blood sugar levels. Dapagliflozin is the international nonproprietary name inn, and the united states adopted name usan. Pdf dapagliflozin for the treatment of type 2 diabetes. Dapagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Finding and evaluating generic and branded drug market entry opportunities. Do not start, stop, or change the dose of any drug without checking with your doctor. Xigduo xr dapagliflozin and metformin hcl extended. In 2012 fda delayed the approval of dapagliflozin partly because of concerns. Farxiga dapagliflozin is a firstinclass, oral oncedaily sglt2. Update on longterm efficacy and safety of dapagliflozin in patients. What is known about this drug in comparison with other combination therapies, both dapagliflozin and canagliflozin provide similar improvements in hba 1c level when combined. Farxiga dapagliflozin dosing, indications, interactions. The full text of this article is available in pdf format. The prescription drug user fee act date, the fda action date for this. Dapagliflozin metformin was approved for use in the european union in january 2014, 4 and for use in the united states in february. On 19 january 2012 the us food and drug administration fda did not approve the use of dapagliflozin due to concerns of increased risk of breast and. Dapagliflozin 3oglucuronide accounted for 61% of a 50 mg 14 c dapagliflozin dose and is the predominant drug related component in human plasma.

Dapagliflozin works by helping the kidneys get rid of glucose from your bloodstream. Sodium glucose cotransporter type 2 sglt2 inhibitors moving beyond targets nicholas cole helbling pharmd bcps. The aim of this research was to differentiate dapagliflozin, empagliflozin, and canagliflozin based on their capacity to inhibit sodium. Fhea, fbphs, in medical pharmacology and therapeutics fifth edition, 2018. The us food and drug administration fda, followed by the european medicine agency. Dailymed farxiga dapagliflozin tablet, film coated. Xigduo xr dapagliflozin and metformin hcl extendedrelease. There is a combination product dapagliflozin metformin extendedrelease, called xigduo xr. The recommended dose of qtern is a 10 mg dapagliflozin5 mg saxagliptin. Dapagliflozin reduced the risk of worsening heart failure events and cardiovascular death and improved symptoms. Dapagliflozin propanediol monograph for professionals. There is a vast, ambitious, and promising ongoing clinical investigation program with dapagliflozin and other sglt2 inhibitors, which may result in changes to the therapeutic approach to hf in a relatively short time. Tell all of your health care providers that you take dapagliflozin.

The secondary composite outcome hospitalization for hf or death from cardiovascular causes was also lower in the dapagliflozin group than in the placebo group. Addendum to fda briefing document advisory committee meeting december 12 20 for dapagliflozin. Chairman and members of the endocrinologic and metabolic drugs advisory committee. Canagliflozin was approved with the same indication. Effect of dapagliflozin on worsening heart failure and. Dapagliflozin is not known to have any meaningful drug drug. Information on submitting spl files using elist may be found in the guidance for industry spl. What links here related changes upload file special pages permanent link page information. In february 2017, the fda approved a oncedaily combination of dapagliflozin. Efficacy and safety of dapagliflozin, added to therapy of patients with type 2 diabetes with inadequate glycemic control on insulin the safety and scientific validity of this. In patients treated with dapagliflozin, a nonsignificant excess number of breast and bladder. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Dapagliflozin farxiga is an oral medication used to improve glycemia blood glucose control in patients with type 2 diabetes.

Farxiga dapagliflozin is indicated as an adjunct to diet and exercise to improve. Used in the formo f its propanediol monohydrate to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. An fda advisory committee recommended against approving the drug at a july meeting by a 96 vote, citing concern over potential breast and bladder cancer risks dapagliflozin. Bristolmyers squibb application no 202293 approval date. National pbm drug monograph dapagliflozin farxiga vha pharmacy benefits management strategic healthcare group medical advisory panel and visn pharmacist executives the purpose of vaco pbmshg drug monographs is to provide a comprehensive drug. Dapagliflozin propanediol pharmacokinetics absorption bioavailability. It is a combination of dapagliflozin and metformin. Sodium glucose cotransporter type 2 sglt2 inhibitors. Dapagliflozin is 78% bioavailable and rapidly absorbed.

694 1280 1133 602 209 360 291 221 1311 80 939 1078 1512 1147 522 1444 1087 1396 751 1461 938 537 730 18 357 508 154 258 1197 877 193 177 117 1139 1116 1334 106 1172 553